Capital Structure

All articles tagged with "Capital Structure"

5 articles

MSTR 10-K Analysis: Why Strategy Trades Below Its Own Bitcoin

At year-end 2025, Strategy Inc was worth $8.85 billion less than its bitcoin. The 17.3% NAV discount, $883 million in annual fixed obligations against negative operating cash flow, and a BTC Yield metric that fell from 74.3% to 22.8% reveal a capital structure approaching a sustainability threshold. This is what Strategy's 10-K tells you that the Bitcoin headlines don't.

16 min read
Read article

VG 10-K Analysis: The Margin Lifecycle Behind Venture Global's 7.3x Multiple

Venture Global generated $6.6 billion in operating cash flow — nearly triple its $2.3 billion in GAAP net income — yet trades at 7.3x EV/EBITDA, a 32% discount to infrastructure peers. The 10-K reveals why: Calcasieu's post-COD quarterly margin collapsed 36.2 percentage points, CP2's cost estimate escalated $4 billion in one quarter with no explanation, and preferred shareholders capture 58% of the total dividend payout. The margin lifecycle is quantifiable — and the market appears to be pricing it correctly.

15 min read
Read article

EIX 10-K Analysis: Wildfire Recovery Works — Until Customers Can't Pay

Edison International reported $11.55 in earnings per share for FY2025 — a 249% surge that pushed its PE ratio to 5.2x. But $2,591 million of that earnings explosion was non-core wildfire settlement recoveries, and core EPS was just $6.55. Meanwhile, the Eaton Fire recovery framework absorbed 98.7% of initial claims at just $13 million pre-tax net cost to shareholders. The catch: customer bad debts tripled to $397 million — 4.1% of authorized revenue — threatening the ratepayer-funded mechanism that makes the framework work. At $60 per share, Edison isn't just a wildfire bet — it's a bet on whether the recovery framework survives its own funding source deteriorating.

15 min read
Read article

MDLN 10-K Analysis: Why Medline's Growth Story Is a Leveraged Margin Trap

Medline Inc. grew revenue 11.5% to $28.4 billion — the fastest among its med-surg peers. But the 10-K reveals that $2.9 billion in new revenue produced just $67 million in incremental operating income, a 2.3% capture rate below the company's own cost of debt. With ROIC at 5.96% versus a 6.50% cost of debt, a Q4 gross margin cliff to 24.6%, and a potential $11 billion Tax Receivable Agreement owed to PE sponsors, the filing documents a capital structure that demands more than operations can deliver.

15 min read
Read article